BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20241106T110000
DTEND;TZID=Europe/Stockholm:20241106T120000
DTSTAMP:20260417T141756
CREATED:20240919T091445Z
LAST-MODIFIED:20240926T111706Z
UID:173227-1730890800-1730894400@www.scilifelab.se
SUMMARY:Maximising exclusivity for Academic Startups\, Pharma and Biotech Companies in the Life Sciences
DESCRIPTION:Welcome to this Drug Discovery Webinar\, organized by OligoNova and SciLifeLab Drug Discovery and Development\, to learn more about how academic and biotech interventions can be protected with the goal to benefit patients. \n\n\n\nJoin us for an insightful seminar focusing on strategies to maximize the exclusivity of medicinal products in the marketplace.  This session will delve into the intricacies of regulatory intellectual property (IP)\, including patenting strategies\, patent term extensions such as Supplementary Protection Certificates (SPCs)\, and regulatory exclusivities like data and market exclusivity. Additionally\, we will explore further exclusivities available for orphan and paediatric medicines. \n\n\n\nThe seminar will emphasise the critical role of exclusivity in attracting and securing investor interest. Gain valuable knowledge on how to navigate and leverage these mechanisms to extend the market life of your medicinal products effectively\, thereby enhancing their appeal to potential investors. \n\n\n\nregistration\n\n\n\nAgenda \n\n\n\n\nIntroduction – Fredrik Wångsell\, OligoNova\n\n\n\nMaximizing exclusivity in the Life Sciences – Fiona Hey\, Tony Proctor and Michel Pears\, Potter Clarkson\n\n\n\nQ&A and discussion\n\n\n\n\nOne follow-up webinar will take place later this year <ADD LINK> \n\n\n\nWelcome \n\n\n\nSciLifeLab DDD and OligoNova \n\n\n\nOther Seminars\n\n\n\nOligaNova organizes three seminars during the fall 2024 \n\n\n\nTrade secrets in the Life Sciences\, October 15 \n\n\n\nMaximizing exclusivity in the Life Sciences\, November 6 \n\n\n\nIP Strategies in the Life Sciences\, December 18
URL:https://www.scilifelab.se/event/maximizing-exclusivity-in-the-life-sciences/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="OligoNova - Part of the Drug Discovery and Development Platform":MAILTO:par.matsson@oligonova.org
END:VEVENT
END:VCALENDAR